| Date Filed | Type | Description |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/24/2023 |
4
| Boyce Sarah (President and CEO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 50,000 shares
@ $0
Granted 400,000 options to buy
@ $22.47, valued at
$9M
|
|
| 11/14/2022 |
4
| Boyce Sarah (Director) has filed a Form 4 on OmniAb, Inc.|
Txns:
| Bought 21,000 shares
@ $2.7427, valued at
$57.6k
Bought 15,000 shares
@ $2.92, valued at
$43.8k
|
|
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/26/2022 |
4
| Boyce Sarah (President and CEO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 35,045 shares
@ $22.7971, valued at
$798.9k
Sold 14,855 shares
@ $23.069, valued at
$342.7k
Exercised 35,045 options to buy
@ $1.24, valued at
$43.5k
Exercised 14,855 options to buy
@ $1.24, valued at
$18.4k
|
|
| 08/17/2022 |
4
| Boyce Sarah (President and CEO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Sold 100 shares
@ $22.47, valued at
$2.2k
Exercised 100 options to buy
@ $1.24, valued at
$124 |
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2022 |
4
| Boyce Sarah (President and CEO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 425,000 options to buy
@ $14.22, valued at
$6M
|
|
| 06/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Boyce Sarah (Director) has filed a Form 4 on Berkeley Lights, Inc.|
Txns:
| Granted 1,400 shares
@ $0
Granted 4,900 options to buy
@ $37.13, valued at
$181.9k
|
|
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Boyce Sarah (President and CEO) has filed a Form 4 on Avidity Biosciences, Inc.|
Txns:
| Granted 300,000 options to buy
@ $22.34, valued at
$6.7M
|
|
| 07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/12/2020 |
4
| Boyce Sarah (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 831 shares
@ $0
Granted 2,468 options to buy
@ $117.58, valued at
$290.2k
|
|
| 06/11/2020 |
3
| Boyce Sarah (President and CEO) has filed a Form 3 on Avidity Biosciences, Inc. |
| 10/16/2019 |
4
| Boyce Sarah (Director) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 1,431 shares
@ $0
Granted 5,283 options to buy
@ $107.81, valued at
$569.6k
|
|
| 10/15/2019 |
3
| Boyce Sarah (Director) has filed a Form 3 on LIGAND PHARMACEUTICALS INC |
| 07/17/2019 |
4
| Boyce Sarah (President) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Sold 1,819 shares
@ $23.52, valued at
$42.8k
|
|
| 07/03/2019 |
4
| Boyce Sarah (President) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 813 shares
@ $20.043, valued at
$16.3k
|
|
| 01/04/2019 |
4
| Boyce Sarah (President) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 173,000 options to buy
@ $30.73, valued at
$5.3M
|
|
| 04/18/2018 |
4
| Boyce Sarah (President) has filed a Form 4 on AKCEA THERAPEUTICS, INC.|
Txns:
| Granted 20,894 shares
@ $0
Granted 1,000,000 options to buy
@ $23.93, valued at
$23.9M
|
|
| 04/18/2018 |
3
| Boyce Sarah (President) has filed a Form 3 on AKCEA THERAPEUTICS, INC. |
| 01/17/2018 |
4
| Boyce Sarah (Chief Business Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Sold 2,196 shares
@ $51.76, valued at
$113.7k
Granted 12,916 restricted stock units
@ $0
Exercised 5,367 restricted stock units
@ $0 |
|
| 01/02/2018 |
4
| Boyce Sarah (Chief Business Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Acquired 491 shares
@ $42.755, valued at
$21k
Granted 58,125 options to buy
@ $49.25, valued at
$2.9M
|
|
| 07/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/04/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/01/2016 |
4
| Boyce Sarah (Chief Business Officer) has filed a Form 4 on IONIS PHARMACEUTICALS INC|
Txns:
| Acquired 403 shares
@ $20.757, valued at
$8.4k
|
|